FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20220719E00397
1. Date of relevant event: 14/07/2022
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06667
4. Name of listed corporation: Mega Genomics Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 239,233,800
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) YU
(Other names) RONG
10. Name of director (Chinese): 俞熔 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1711Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box)
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
2501Other (you must describe the capacity in the Supplementary Information box)
 		 44,795,135         
 
Short position 
1312There has been a change in nature of your interest in the shares because:
the shares lent by you have been returned to you
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
 		 1,794,200           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position44,795,13518.73
Short position1,794,2000.75
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position44,795,13518.73
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position22,795,135
2501Other (you must describe the capacity in the Supplementary Information box)
Long position22,000,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
YURONG TECHNOLOGY LIMITED2/F, PALM GROVE HOUSE, P.O. BOX 3340, ROAD TOWN, TORTOLA, BRITISH VIRGIN ISLANDS (BRITISH VIRGIN ISLANDS)YU RONG100.00Y
Long position14,555,731
Tianjin Hongzhi Kangjian Management Consulting Partnership (LP) (天津鴻智康健管理諮詢合夥企业 (有限合夥))ROOM 1210, WENFENG DASHA, NO. 872, NINGHAI ROAD, TANGGU OCEAN SCIENCE AND TECHNOLOGY PARK, BINHAI GAOXIN DISTRICT, TIANJIN, PEOPLE'S REPUBLIC OF CHINA (PEOPLE'S REPUBLIC OF CHINA )Zhuhai Zhongwei Yijian Equity Investment Fund (LP) (珠海中衛易健股權投資基金(有限合夥))99.00Y
Long position8,239,404
Tianjin Hongzhi Kangjian Management Consulting Partnership (LP) (天津鴻智康健管理諮詢合夥企业 (有限合夥))ROOM 1210, WENFENG DASHA, NO. 872, NINGHAI ROAD, TANGGU OCEAN SCIENCE AND TECHNOLOGY PARK, BINHAI GAOXIN DISTRICT, TIANJIN, PEOPLE'S REPUBLIC OF CHINA (PEOPLE'S REPUBLIC OF CHINA )Shanghai Zhongfu Equity Investment Management Co., Ltd. (上海中孵創業投資管理有限公司)1.00Y
Long position8,239,404
Zhuhai Zhongwei Yijian Equity Investment Fund (LP) (珠海中衛易健股權投資基金(有限合夥))中國珠海市橫琴新區寶華路6號105室-21025 (中國)E Fund Asset Management Co., Ltd. (易方達資產管理有限公司)73.00N
Long position8,239,404
Zhuhai Zhongwei Yijian Equity Investment Fund (LP) (珠海中衛易健股權投資基金(有限合夥))中國珠海市橫琴新區寶華路6號105室-21025 (中國)Shanghai Tianyi Asset Management Co., Ltd. (上海天億資產管理有限公司)16.90N
Long position8,239,404
Zhuhai Zhongwei Yijian Equity Investment Fund (LP) (珠海中衛易健股權投資基金(有限合夥))中國珠海市橫琴新區寶華路6號105室-21025 (中國)Shanghai Zhongfu Equity Investment Management Co., Ltd. (上海中孵創業投資管理有限公司)0.10N
Long position8,239,404
Shanghai Zhongfu Equity Investment Management Co., Ltd. (上海中孵創業投資管理有限公司)中國上海市崇明區港沿鎮港沿公路1700號6幢1691室（上海港沿經濟小區）(中國)Shanghai Tianyi Asset Management Co., Ltd. (上海天億資產管理有限公司)100.00N
Long position8,239,404
Shanghai Tianyi Asset Management Co., Ltd. (上海天億資產管理有限公司)中國上海市崇明區港沿鎮港沿公路1700號3幢11893室（上海港沿經濟小區）(中國)YU RONG70.00N
Long position8,239,404
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Pursuant to the voting rights entrustment deed, Infinite Galaxy Health Limited ("Infinite") entrusts Dr. Yu to exercise all voting rights associated with the 22,000,000 shares it held. Infinite lent 1,794,200 shares of the Company to China Securities (International) Corporate Finance Company Limited pursuant to a stock borrowing agreement and such shares have been fully returned to Infinite on 14/7/2022. Such 1,794,200 shares constitute part of 22,000,000 shares held by Infinite in the Company.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 19/07/2022
(dd/mm/yyyy)